Davis Jerel - Net Worth and Insider Trading
Davis Jerel Net Worth
The estimated net worth of Davis Jerel is at least $147 Million dollars as of 2024-12-27. Davis Jerel is the Director of Chinook Therapeutics Inc and owns about 3,478,920 shares of Chinook Therapeutics Inc (KDNY) stock worth over $141 Million. Davis Jerel is the Director of Repare Therapeutics Inc and owns about 3,315,739 shares of Repare Therapeutics Inc (RPTX) stock worth over $4 Million. Davis Jerel is also the Director, 10% Owner of Turnstone Biologics Corp and owns about 3,381,692 shares of Turnstone Biologics Corp (TSBX) stock worth over $2 Million. Details can be seen in Davis Jerel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Davis Jerel has not made any transactions after 2023-07-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Davis Jerel
Davis Jerel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Davis Jerel owns 5 companies in total, including Aduro Biotech Inc (ADRO) , Repare Therapeutics Inc (RPTX) , and Chinook Therapeutics Inc (KDNY) among others .
Click here to see the complete history of Davis Jerel’s form 4 insider trades.
Insider Ownership Summary of Davis Jerel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADRO | Aduro Biotech Inc | 2020-10-05 | director |
| RPTX | Repare Therapeutics Inc | 2022-12-09 | director & 10 percent owner |
| KDNY | Chinook Therapeutics Inc | 2023-04-17 | director & 10 percent owner |
 | | 2021-06-24 | director & 10 percent owner |
| | 2023-07-25 | director & 10 percent owner |
Davis Jerel Latest Holdings Summary
Davis Jerel currently owns a total of 3 stocks. Among these stocks, Davis Jerel owns 3,478,920 shares of Chinook Therapeutics Inc (KDNY) as of April 17, 2023, with a value of $141 Million and a weighting of 95.9%. Davis Jerel owns 3,315,739 shares of Repare Therapeutics Inc (RPTX) as of December 9, 2022, with a value of $4 Million and a weighting of 2.99%. Davis Jerel also owns 3,381,692 shares of Turnstone Biologics Corp (TSBX) as of July 25, 2023, with a value of $2 Million and a weighting of 1.11%.
Latest Holdings of Davis Jerel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KDNY | Chinook Therapeutics Inc | 2023-04-17 | 3,478,920 | 40.39 | 140,513,579 |
| RPTX | Repare Therapeutics Inc | 2022-12-09 | 3,315,739 | 1.32 | 4,376,775 |
| TSBX | Turnstone Biologics Corp | 2023-07-25 | 3,381,692 | 0.48 | 1,623,212 |
Holding Weightings of Davis Jerel
Davis Jerel Form 4 Trading Tracker
According to the SEC Form 4 filings, Davis Jerel has made a total of 2 transactions in Chinook Therapeutics Inc (KDNY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Chinook Therapeutics Inc is the sale of 295,808 shares on April 17, 2023, which brought Davis Jerel around $6 Million.
According to the SEC Form 4 filings, Davis Jerel has made a total of 3 transactions in Repare Therapeutics Inc (RPTX) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Repare Therapeutics Inc is the sale of 250,000 shares on December 9, 2022, which brought Davis Jerel around $4 Million.
According to the SEC Form 4 filings, Davis Jerel has made a total of 1 transactions in Turnstone Biologics Corp (TSBX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Turnstone Biologics Corp is the acquisition of 225,000 shares on July 25, 2023, which cost Davis Jerel around $3 Million.
Insider Trading History of Davis Jerel
- 1
Davis Jerel Trading Performance
GuruFocus tracks the stock performance after each of Davis Jerel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Davis Jerel is -39.97%. GuruFocus also compares Davis Jerel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Davis Jerel within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Davis Jerel's insider trading performs compared to the benchmark.
Performance of Davis Jerel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.22 | | | | | |
| Relative Return to S&P 500(%) | -18.12 | | | | | |
Davis Jerel Ownership Network
Davis Jerel Owned Company Details
What does Aduro Biotech Inc do?
Who are the key executives at Aduro Biotech Inc?
Davis Jerel is the director of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include director & President & CEO Eric Dobmeier , 10 percent owner Versant Voyageurs I, L.p. , and 10 percent owner Versant Voyageurs I Parallel, L.p. .
Aduro Biotech Inc (ADRO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aduro Biotech Inc Insider Transactions
Davis Jerel Mailing Address
Above is the net worth, insider trading, and ownership report for Davis Jerel. You might contact Davis Jerel via mailing address: One Sansome Street, Suite 3630, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
